Comments On The 2023 Update Of The 2021 Esc Guidelines For The Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD, discuss the use of beta-blocker therapy following acute MI Medscape spoke with Professor Zhenyue Chen of Shanghai Jiao Tong University of Medicine in China about her research into the lipids that increase ASCVD risk
Esc 365 2023 Focused Update Of The 2021 Esc Guidelines For The There are limited treatment options for the large population of patients with heart failure (HF) and mildly reduced or preserved ejection fraction (HFmrEF/HFpEF) In the FINEARTS-HF trial, finerenone
Comments are closed.